[EN] TETRAHYDRO[1,8]NAPHTHYRIDINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORƴ AND THE TREATMENT OF DISEASE<br/>[FR] TÉTRAHYDRO[1,8]NAPHTYRIDINE-SULFONAMIDE ET COMPOSÉS APPARENTÉS POUR UTILISATION EN TANT QU'AGONISTES DE RORGamma ET DANS LE TRAITEMENT D'UNE MALADIE
申请人:LYCERA CORP
公开号:WO2013169864A2
公开(公告)日:2013-11-14
The invention provides tetrahydro[1,8]naphthyridine and related compounds, pharmaceutical compositions, methods of promoting RORƴ activity, increasing the amount of IL-17 in a subject, and treating cancer using such tetrahydro[1,8]naphthyridine and related compounds.